Three patients with Her2-positive disease discontinued treatment: one received three cycles of TCbHP regimen and discontinued due to acute kidney injury, another one stopped after receiving five out of six cycles due to diarrhea and hypokalemia, and the third one discontinued pertuzumab due to severe diarrhea. The gene discussed is ERBB2; the disease is Hypokalemia.